Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 6, 2010

View Archived Issues

GSK to develop Anacor's new antibiotic for Gram-negative infections

Bristol-Myers Squibb claims new JAK2 inhibitors

Santhera discloses new MC4 receptor antagonists

New FPS inhibitors discovered at Novartis

Dr. Reddy's Laboratories and Pulmagen Therapeutics claim new PPAR-gamma agonists

CANOE trial data support use of Avandamet to prevent type 2 diabetes

Scientists report regional changes in brain gray matter density in patients with IBS

PF-3845 has antiallodynic effects in preclinical study

Scientists explore neuroprotective role of URB-597 in models of retinal neurodegeneration

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Telormedix and Swiss TPH join to study TMX-201 in malaria and Buruli ulcer

TapImmune and Mayo Clinic partner to develop smallpox vaccine technology

FDA issues complete response letter for Luveniq NDA in noninfectious uveitis

Gemin X secures funding for obatoclax development

Resolor approved in Switzerland for idiopathic chronic constipation

FDA accepts NDA for gadobutrol injection in MRI of CNS

BrainCells acquires Proximagen's sabcomeline for major depressive disorder

Affymax and Takeda outline U.S. registration strategy for Hematide

FDA approves new docetaxel injection concentrate formulation for cancer

YM concludes dose escalation in phase I CYT-387 trial in myelofibrosis

EMA's CHMP issues positive opinion on Relistor in prefilled syringes

Vicept presents clinical data on V-101 in rosacea-associated erythema

NIH provides grant for phase I/II AEZS-108 trial in advanced prostate cancer

Tekmira files IND application with FDA for PLK1-SNALP in solid tumors

Takeda presents new glucokinase activators

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...